Petronilho, S.; Sequeira, J.P.; Paulino, S.; Lopes, P.; Lisboa, S.; Chacim, S.; Lobo, J.; Teixeira, M.; Jerónimo, C.; Henrique, R.
Prognostic Value of Histone Modifying Enzyme EZH2 in RCHOP-Treated Diffuse Large B-Cell Lymphoma and High Grade B-Cell Lymphoma. J. Pers. Med. 2021, 11, 1384.
https://doi.org/10.3390/jpm11121384
AMA Style
Petronilho S, Sequeira JP, Paulino S, Lopes P, Lisboa S, Chacim S, Lobo J, Teixeira M, Jerónimo C, Henrique R.
Prognostic Value of Histone Modifying Enzyme EZH2 in RCHOP-Treated Diffuse Large B-Cell Lymphoma and High Grade B-Cell Lymphoma. Journal of Personalized Medicine. 2021; 11(12):1384.
https://doi.org/10.3390/jpm11121384
Chicago/Turabian Style
Petronilho, Sara, José Pedro Sequeira, Sofia Paulino, Paula Lopes, Susana Lisboa, Sérgio Chacim, João Lobo, Manuel Teixeira, Carmen Jerónimo, and Rui Henrique.
2021. "Prognostic Value of Histone Modifying Enzyme EZH2 in RCHOP-Treated Diffuse Large B-Cell Lymphoma and High Grade B-Cell Lymphoma" Journal of Personalized Medicine 11, no. 12: 1384.
https://doi.org/10.3390/jpm11121384
APA Style
Petronilho, S., Sequeira, J. P., Paulino, S., Lopes, P., Lisboa, S., Chacim, S., Lobo, J., Teixeira, M., Jerónimo, C., & Henrique, R.
(2021). Prognostic Value of Histone Modifying Enzyme EZH2 in RCHOP-Treated Diffuse Large B-Cell Lymphoma and High Grade B-Cell Lymphoma. Journal of Personalized Medicine, 11(12), 1384.
https://doi.org/10.3390/jpm11121384
